This inventor holds 3 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1989-1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989-1991
Title: Innovations by Matthias Schuller
Introduction
Matthias Schuller is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of antiviral treatments, holding a total of three patents. His work focuses on innovative methods for treating viral infections in patients.
Latest Patents
Schuller's latest patents include methods for treating viruses in patients by administering an antivirally effective amount of a substituted hydroxypiperidine. This includes a specific compound known as 2-hydroxymethylene-3,4,5-trihydroxypiperidine. Additionally, he has developed N-substituted derivatives of 1-desoxynojirimycin and 1-desoxymannojirimycin, which are crucial in the treatment of viral infections.
Career Highlights
Matthias Schuller is currently employed at Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on groundbreaking research and development in antiviral therapies.
Collaborations
Some of his notable coworkers include Horst Boshagen and Bodo Junge, who have collaborated with him on various projects related to antiviral research.
Conclusion
Matthias Schuller is a prominent inventor whose work in antiviral treatments has the potential to impact the medical field significantly. His innovative approaches and collaborations continue to drive advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile